Moderator: 3ne2nr Mods
redmanjp wrote:De Dragon wrote:redmanjp wrote:De Dragon wrote:Are these jackarses positing that all airlines should have been grounded before removal of the mandate?
no just either a heads up or an announcement that teh airline itself would remove it by a certain date.
does AATT have any say in the mask mandate for flights between T&T and US?
What heads up did you expect?![]()
It was a court ordered removal, NOT a policy one
the airline can have its own mandate which they did before any federal mandate, so they could decide to continue to require it for a few days while they notify customers with booked tickets.
maj. tom wrote:Anyone read the ruling and the reason? The reason why not to wear a mask?
Republican supporters (and the local trickle down facebook idiots) can't get more stupidly manipulated than this.
(Or can they!) *zoom in intensifies*“Wearing a mask cleans nothing,” U.S. District Judge Kathryn Kimball Mizelle wrote in her decision on Monday. “At most, it traps virus droplets. But it neither ‘sanitizes’ the person wearing the mask nor ‘sanitizes’ the conveyance.”
Mizelle, 35, was only eight years out of law school at University of Florida when Trump appointed her to the lifetime position in 2020. The Daily Beast noted at the time that her only trial experience was as an intern, and that she held four clerkships, including one for Supreme Court Justice Clarence Thomas. Mizelle was rated “not qualified” by the American Bar Association prior to her appointment, citing her lack of experience.
https://www.rollingstone.com/politics/p ... e-1339427/
st7 wrote:some people here dont have day jobs rather than post more and more sheit about being against vaccines etc?
level beat up oui
st7 wrote:max, how old you is? i see you keep trying to make fun of my handle like a high school girl.
i imagine it must make your day giving me that special attention : )
Max,MaxPower wrote:st7 wrote:some people here dont have day jobs rather than post more and more sheit about being against vaccines etc?
level beat up oui
stD,
You eh fed up macoo and watch other people?
Hadda mind your own business bro
So in essence:sMASH wrote:Another study TREATING covid with ivermectin,
When ur supposed to have ivermectin in ur system BEFORE infection.
sMASH wrote:Another study TREATING covid with ivermectin,
When ur supposed to have ivermectin in ur system BEFORE infection.
sMASH wrote:Still alive, no jab...
Or according to authorities metrics, I fall into the 'not fully vaxed' group.
matix wrote:sMASH wrote:Still alive, no jab...
Or according to authorities metrics, I fall into the 'not fully vaxed' group.
How many times have you taken ivermectin?
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator
22 April 2022 Statement Geneva Reading time: 2 min (592 words)
Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date. However, availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before administering it, are turning this life-saving medicine into a major challenge for low- and middle-income countries.
Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such as unvaccinated, older, or immunosuppressed patients.
This recommendation is based on new data from two randomized controlled trials involving 3078 patients. The data show that the risk of hospitalization is reduced by 85% following this treatment. In a high-risk group (over 10% risk of hospitalization), that means 84 fewer hospitalizations per 1000 patients.
WHO suggests against its use in patients at lower risk, as the benefits were found to be negligible.
One obstacle for low- and middle-income countries is that the medicine can only be administered while the disease is at its early stages; prompt and accurate testing is therefore essential for a successful outcome with this therapy. Data collected by FIND show that the average daily testing rate in low-income countries is as low as one-eightieth the rate in high-income countries. Improving access to early testing and diagnosis in primary health care settings will be key for the global rollout of this treatment.
WHO is extremely concerned that -- as occurred with COVID-19 vaccines -- low- and middle-income countries will again be pushed to the end of the queue when it comes to accessing this treatment.
Lack of transparency on the part of the originator company is making it difficult for public health organizations to obtain an accurate picture of the availability of the medicine, which countries are involved in bilateral deals and what they are paying. In addition, a licensing agreement made by Pfizer with the Medicines Patent Pool limits the number of countries that can benefit from generic production of the medicine.
The originator product, sold under the name Paxlovid, will be included in the WHO prequalification list today, but generic products are not yet available from quality-assured sources. Several generic companies (many of which are covered by the licensing agreement between the Medicines Pool and Pfizer) are in discussion with WHO Prequalification but may take some time to comply with international standards so that they can supply the medicine internationally.
WHO therefore strongly recommends that Pfizer make its pricing and deals more transparent and that it enlarge the geographical scope of its licence with the Medicines Patent Pool so that more generic manufacturers may start to produce the medicine and make it available faster at affordable prices.
Along with the strong recommendation for the use of nirmatrelvir and ritonavir, WHO has also updated its recommendation on remdesivir, another antiviral medicine.
Previously, WHO had suggested against its use in all COVID-19 patients regardless of disease severity, due to the totality of the evidence at that time showing little or no effect on mortality. Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation. WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization.
The recommendation for use of remdesivir in patients with severe or critical COVID-19 is currently under review.
redmanjp wrote:matix wrote:sMASH wrote:Still alive, no jab...
Or according to authorities metrics, I fall into the 'not fully vaxed' group.
How many times have you taken ivermectin?
that is good if u have a parasitic infection and also end up in hospital being treated for covid- i think someone posted a study suggesting a benefit in the case where the covid treatment which suppresses the immune system to tackle the inflammatory response ends up allowing the parasitic infection to get out of control (as the immune system is essentially disabled) so u eventually die, but from that infection, not from covid. the ivermectin helps deal with the infection, which is why some studies showed a benefit - but they did not look at the actual cause of death.
So was marijuana.sMASH wrote:redmanjp wrote:matix wrote:sMASH wrote:Still alive, no jab...
Or according to authorities metrics, I fall into the 'not fully vaxed' group.
How many times have you taken ivermectin?
that is good if u have a parasitic infection and also end up in hospital being treated for covid- i think someone posted a study suggesting a benefit in the case where the covid treatment which suppresses the immune system to tackle the inflammatory response ends up allowing the parasitic infection to get out of control (as the immune system is essentially disabled) so u eventually die, but from that infection, not from covid. the ivermectin helps deal with the infection, which is why some studies showed a benefit - but they did not look at the actual cause of death.
since april 2020, very early on, a dr was saying, that the virus is dead 10 days after the initial infection. so, up to that time, u administer anti virals to kill the virus. but after that 10 days, u administer immuno supressants and anti inflamatories.
which makes sense, cause the major problem with covid is the body's own response,, over acting, killing itself ... the cytokine storm.
the ivermectin was observed to have the protease inhibitor effect. where it just interrupts the virus from attaching to the receptor sites of cells. so, blocking infection in that way. but, that will only work if its in the body circulating in enough quantities, compared to the virus cells.
so, taking it when ur already infected, means u have to take enough, and it must reach the area of infection (lung tissue) in quantities to be comparable to the viral cells, and not be overshelemed by the sheer amount of viral cells.
all that means is, u need to take it as early as possible to avoid the virus from infecting and spreading. cause the virus can out replicate the cells that get blocked. and covid replicates very quickly.
but u only need to keep it at bay for 10 days, until ur body can over come it.
so, the best thing is to have it well distributed in ur body before hand.
i was supposed to take the ivermectin at teh beginning of february, but didnt, cause i wanted to ensure i get exposure to omicron.
Make you calm tf down, want to hug everybody and raid their fridge?sMASH wrote:but the mental effects... hmmmm, lol
Return to “Ole talk and more Ole talk”
Users browsing this forum: Snyper and 99 guests